NOVARTIS
- Country
- 🇨🇭Switzerland
- Ownership
- Public, Private
- Established
- 1996-01-01
- Employees
- 76K
- Market Cap
- $242.6B
Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD
- Conditions
- ADHD
- First Posted Date
- 2005-09-01
- Last Posted Date
- 2007-12-21
- Lead Sponsor
- Novartis
- Target Recruit Count
- 90
- Registration Number
- NCT00141050
- Locations
- 🇺🇸
Bayou City Research, Houston, Texas, United States
Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD
- Conditions
- ADHD
- First Posted Date
- 2005-09-01
- Last Posted Date
- 2007-12-21
- Lead Sponsor
- Novartis
- Target Recruit Count
- 90
- Registration Number
- NCT00141063
- Locations
- 🇺🇸
Center for Psychiatry & Behavioral Medicine, Las Vegas, Nevada, United States
Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension
- Conditions
- HypertensionLeft Ventricular Hypertrophy
- First Posted Date
- 2005-08-31
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Novartis
- Target Recruit Count
- 125
- Registration Number
- NCT00139555
- Locations
- 🇺🇸
Novartis Pharmaceuticals, East Hanover, New Jersey, United States
Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder
- Conditions
- Bipolar Disorder
- Interventions
- Drug: licarbazepine
- First Posted Date
- 2005-08-31
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Novartis
- Target Recruit Count
- 181
- Registration Number
- NCT00139594
- Locations
- 🇺🇸
Investigational site, La Palma, California, United States
🇻🇪Novartis Investigational Site, Caracas, Venezuela
🇨🇦Novartis Investigator Site, Vancouver, Canada
Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric Subjects
- First Posted Date
- 2005-08-31
- Last Posted Date
- 2008-04-23
- Lead Sponsor
- Novartis
- Registration Number
- NCT00139581
- Locations
- 🇨🇭
This study is not being conducted in the United States, Novartis Pharma AG, Basel, Switzerland
An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to Chinese Patients With Chronic Constipation
- Conditions
- Constipation
- First Posted Date
- 2005-08-31
- Last Posted Date
- 2008-02-01
- Lead Sponsor
- Novartis
- Target Recruit Count
- 600
- Registration Number
- NCT00139568
- Locations
- 🇨🇭
Novartis, Basel, Switzerland
Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes
- Conditions
- Diabetes Mellitus, Type 2
- First Posted Date
- 2005-08-30
- Last Posted Date
- 2017-03-01
- Lead Sponsor
- Novartis
- Target Recruit Count
- 345
- Registration Number
- NCT00138580
- Locations
- 🇺🇸
Novartis Pharmaceuticals, East Hanover, New Jersey, United States
Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes
- Conditions
- Diabetes Mellitus, Type 2
- First Posted Date
- 2005-08-30
- Last Posted Date
- 2012-05-07
- Lead Sponsor
- Novartis
- Target Recruit Count
- 478
- Registration Number
- NCT00138619
- Locations
- 🇺🇸
Novartis Pharmaceuticals, East Hanover, New Jersey, United States
Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes
- Conditions
- Diabetes Mellitus, Type 2
- First Posted Date
- 2005-08-30
- Last Posted Date
- 2016-11-18
- Lead Sponsor
- Novartis
- Target Recruit Count
- 530
- Registration Number
- NCT00138567
- Locations
- 🇩🇪
Novartis Investigative site, Investigative Centers, Germany
🇺🇸Novartis Investigative Site, East Hanover, New Jersey, United States
Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes
- Conditions
- Diabetes Mellitus, Type 2
- First Posted Date
- 2005-08-30
- Last Posted Date
- 2016-11-18
- Lead Sponsor
- Novartis
- Target Recruit Count
- 179
- Registration Number
- NCT00138606
- Locations
- 🇺🇸
Novartis Pharmaceuticals, East Hanover, New Jersey, United States
🇩🇪Novartis Investigative Site, Investigative Centers, Germany